NCT07156045View on ClinicalTrials.gov

Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Prostate Cancer Castration-resistant Prostate Cancer

Interventions

BIOLOGICAL

anti-PSMA CAR-NK

Targeting PSMA CAR-NK cells

All Listed Sponsors

lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER